MX2021011041A - Compuestos y composiciones que comprenden los mismos para tratar hipertension o fallo cardiaco. - Google Patents
Compuestos y composiciones que comprenden los mismos para tratar hipertension o fallo cardiaco.Info
- Publication number
- MX2021011041A MX2021011041A MX2021011041A MX2021011041A MX2021011041A MX 2021011041 A MX2021011041 A MX 2021011041A MX 2021011041 A MX2021011041 A MX 2021011041A MX 2021011041 A MX2021011041 A MX 2021011041A MX 2021011041 A MX2021011041 A MX 2021011041A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- compositions
- same
- heart failure
- treating hypertension
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010020772 Hypertension Diseases 0.000 title 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- 208000037849 arterial hypertension Diseases 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000001474 proteinuria Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19305286 | 2019-03-11 | ||
| PCT/EP2020/056483 WO2020182870A1 (en) | 2019-03-11 | 2020-03-11 | Compounds and compositions comprising the same for treating hypertension or heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021011041A true MX2021011041A (es) | 2021-10-13 |
Family
ID=65818483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021011041A MX2021011041A (es) | 2019-03-11 | 2020-03-11 | Compuestos y composiciones que comprenden los mismos para tratar hipertension o fallo cardiaco. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11345658B2 (zh) |
| EP (1) | EP3937924B1 (zh) |
| JP (1) | JP2022520494A (zh) |
| KR (1) | KR102401407B1 (zh) |
| CN (1) | CN113784710A (zh) |
| AR (1) | AR118302A1 (zh) |
| AU (1) | AU2020235216B2 (zh) |
| BR (1) | BR112021017158A2 (zh) |
| CA (1) | CA3129677C (zh) |
| EA (1) | EA202192421A1 (zh) |
| ES (1) | ES2965293T3 (zh) |
| IL (1) | IL285593B (zh) |
| MA (1) | MA55275A (zh) |
| MX (1) | MX2021011041A (zh) |
| TW (1) | TW202100146A (zh) |
| WO (1) | WO2020182870A1 (zh) |
| ZA (1) | ZA202107513B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112142629B (zh) * | 2020-10-10 | 2021-09-14 | 西北工业大学 | 3-氨基磺酰基丙氨酸的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2773712B1 (fr) | 1998-01-16 | 2000-06-02 | Inst Nat Sante Rech Med | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a |
| FR2858617A1 (fr) * | 2003-08-06 | 2005-02-11 | Inst Nat Sante Rech Med | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
| EP2439192A1 (en) | 2010-10-07 | 2012-04-11 | Quantum Genomics | Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) |
-
2020
- 2020-03-09 TW TW109107735A patent/TW202100146A/zh unknown
- 2020-03-10 AR ARP200100650A patent/AR118302A1/es unknown
- 2020-03-11 WO PCT/EP2020/056483 patent/WO2020182870A1/en unknown
- 2020-03-11 EA EA202192421A patent/EA202192421A1/ru unknown
- 2020-03-11 CN CN202080020321.1A patent/CN113784710A/zh active Pending
- 2020-03-11 KR KR1020217032594A patent/KR102401407B1/ko active IP Right Grant
- 2020-03-11 IL IL285593A patent/IL285593B/en unknown
- 2020-03-11 JP JP2021554368A patent/JP2022520494A/ja active Pending
- 2020-03-11 EP EP20708139.9A patent/EP3937924B1/en active Active
- 2020-03-11 US US17/437,862 patent/US11345658B2/en active Active
- 2020-03-11 BR BR112021017158A patent/BR112021017158A2/pt unknown
- 2020-03-11 MA MA055275A patent/MA55275A/fr unknown
- 2020-03-11 AU AU2020235216A patent/AU2020235216B2/en active Active
- 2020-03-11 CA CA3129677A patent/CA3129677C/en active Active
- 2020-03-11 ES ES20708139T patent/ES2965293T3/es active Active
- 2020-03-11 MX MX2021011041A patent/MX2021011041A/es unknown
-
2021
- 2021-10-06 ZA ZA2021/07513A patent/ZA202107513B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11345658B2 (en) | 2022-05-31 |
| JP2022520494A (ja) | 2022-03-30 |
| KR20210134037A (ko) | 2021-11-08 |
| ZA202107513B (en) | 2023-01-25 |
| WO2020182870A1 (en) | 2020-09-17 |
| AU2020235216A1 (en) | 2021-09-09 |
| CN113784710A (zh) | 2021-12-10 |
| US20220041548A1 (en) | 2022-02-10 |
| AU2020235216B2 (en) | 2021-12-16 |
| EP3937924A1 (en) | 2022-01-19 |
| BR112021017158A2 (pt) | 2021-11-09 |
| CA3129677C (en) | 2023-01-03 |
| TW202100146A (zh) | 2021-01-01 |
| EA202192421A1 (ru) | 2021-12-22 |
| IL285593A (en) | 2021-09-30 |
| IL285593B (en) | 2022-07-01 |
| ES2965293T3 (es) | 2024-04-12 |
| CA3129677A1 (en) | 2020-09-17 |
| EP3937924B1 (en) | 2023-09-06 |
| MA55275A (fr) | 2022-01-19 |
| KR102401407B1 (ko) | 2022-05-23 |
| AR118302A1 (es) | 2021-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021004741A (es) | Inhibidores de aminopeptidasa a y composiciones farmacéuticas que comprenden el mismo. | |
| RU2008120295A (ru) | Средства и способы для лечения нарушений свертываемости | |
| EP4234017A3 (en) | 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm) | |
| EA201170670A1 (ru) | Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-iv для лечения или предупреждения диабета | |
| NZ716245A (en) | Fused benzoxazepinones as ion channel modulators | |
| MA34397B1 (fr) | Dérivés d'acide napht-2-ylacétique dans le traitement du sida | |
| MX2021004728A (es) | Nuevos derivados aminofosfinicos como inhibidores de aminopeptidasa a. | |
| Hayashi et al. | Anaemia and early phase cardiovascular events on haemodialysis | |
| MX2021011041A (es) | Compuestos y composiciones que comprenden los mismos para tratar hipertension o fallo cardiaco. | |
| MX2021015056A (es) | Compuesto de pirrolopirimidina y uso del mismo. | |
| Pelliccia et al. | Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension | |
| MX2021010700A (es) | Compuestos utiles en la terapia del vih. | |
| AU2020235187A8 (en) | Uses of phosphodiesterase inhibitors | |
| PH12018500501A1 (en) | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders | |
| EA202190841A1 (ru) | Композиции для снижения уровней мочевой кислоты в сыворотке крови | |
| WO2020236690A9 (en) | Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes | |
| MX2023009520A (es) | Compuesto de 4-aminoquinazolina. | |
| MX2021014773A (es) | Formas de sales cristalinas de un inhibidor de cinasas. | |
| EA200900862A1 (ru) | Производные простациклина | |
| MX2023003610A (es) | Compuestos de heteroarilo fusionado y su uso como inhibidores de proteína cinasa ii dependiente de calcio/calmodulina (camkii). | |
| MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
| MX2023004881A (es) | Inhibidores de pde9 para el tratamiento de insuficiencia cardíaca. | |
| MX2022002993A (es) | Rebamipida para usarse en la prevencion y/o tratamiento de la rigidez arterial. | |
| MX2019015075A (es) | Uso de enalapril para tratamiento de rigidez arterial y composiciones que lo contienen. | |
| WO2012122532A3 (en) | Compositions and methods for treatment of hyperuricemia |